This commentary discusses the unmet clinical and social needs associated with hypertrophic scars and keloids. The authors critically appraise these issues within the context of contemporary clinical standards of care and social mores catalyzed by the COVID-19 pandemic.
Journal article
Rejuvenation res
08/2021
24
307 - 309
dermatology, drug development, hypertrophic scars, keloids, regenerative medicine, COVID-19, Cicatrix, Hypertrophic, Health Services Needs and Demand, Humans, Keloid, Pandemics